Skip to main content
Log in

Gene analysis of inherited antithrombin deficiency and functional analysis of abnormal antithrombin protein (N87D)

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Inherited antithrombin (AT) deficiency is one of the most clinically significant forms of congenital thrombophilia and follows an autosomal dominant mode of inheritance. We analyzed SERPINC1 in a patient who developed deep-vein thrombosis and low AT activity during pregnancy, and identified a novel missense mutation c.259A>G (p.Asn87Asp; N87D). Surprisingly, analysis of the parents’ DNA showed that they did not possess this mutant, and thus, it may have been due to a de novo mutation. We also expressed this mutant AT protein in COS-1 cells and compared its intracellular localization and intracellular and extracellular antigen levels with that of wild-type AT. The expression experiment did not reveal a significant difference in the antigen levels of the mutant and wild-type AT in the cell lysate, but the mutant AT antigen level was markedly lower than that of its wild-type counterpart in the COS-1 cell supernatant. Immunofluorescence did not indicate any difference between the mutant and wild-type AT in terms of cytoplasmic localization of fluorescence signals. Our findings suggest that the patient’s AT deficiency may have been caused by impaired extracellular secretion of mutant AT protein p.Asn87Asp.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Perry DJ, Carrell RW. Molecular genetics of human antithrombin deficiency. Hum Mutat. 1996;7(1):7–22.

    Article  CAS  PubMed  Google Scholar 

  2. Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA. 1997;94(26):14683–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Olson ST, Swanson R, Raub-Seqall E, Bedsted T, Sadri M, Petitou M, et al. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. Thromb Heamost. 2004;92(5):929–39.

    CAS  Google Scholar 

  4. Luxembourg B, Deley D, Geisen C, Spannagl M, Krause M, Miesbach W, et al. Molecular basis of antithrombin deficiency. Thromb Heamost. 2011;105(4):635–46.

    Article  CAS  Google Scholar 

  5. Lane DA, Kunz G, Olds RJ, Thein SL. Molecular genetics of antithrombin deficiency. Blood Rev. 1996;10(2):59–74.

    Article  CAS  PubMed  Google Scholar 

  6. Mulder R, Croles FN, Mulder AB, Huntington JA, Meijer K, Lukens MV. SERPINC1 gene mutations in antithrombin deficiency. Br J Haematol. 2017;178(2):279–85.

    Article  CAS  PubMed  Google Scholar 

  7. Sekiya A, Taniguchi F, Yamaguchi D, Kamijima S, Kaneko S, Katsu S, et al. Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients. Int J Hematol. 2017;105(3):287–94.

    Article  CAS  PubMed  Google Scholar 

  8. Maruyama K, Morishita E, Karato M, Kadono T, Sekiya A, Goto Y, et al. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene. Thromb Res. 2013;132(2):e118–23.

    Article  CAS  PubMed  Google Scholar 

  9. Chowdhury V, Olds RJ, Lane DA, Conard J, Pabinger I, Ryan K, et al. Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening. Br J Heamatol. 1993;84(4):656–61.

    Article  CAS  Google Scholar 

  10. Zhou RF, Fu QH, Wang WB, Xie S, Dai J, Ding QL, et al. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis. Thromb Harmost. 2005;94(6):1172–6.

    CAS  Google Scholar 

  11. Tarantino MD, Curtis SM, Johnson GS, Waye JS, Blajchman MA. A novel de novo spontaneous point mutation (Glu271STOP) of the anitithrombin gene results in a type 1 deficiency and thrombophilia. Am J Heamatol. 1999;60(2):126–9.

    Article  CAS  Google Scholar 

  12. Wang TF, Dawson JE, Forman-Kay JD, Kahr WH, Williams S, Chan AK, et al. Molecular structural analysis of a novel and de-novo mutation in the SERPINC1 gene associated with type 1 antithrombin deficiency. Br J Heamatol. 2017;177(4):654–6.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Tsuneo Imanaka for providing the pcDNA3.1/AT expression plasmid. This study was partly supported by a grant from the Ministry of Health, Labor and Welfare to E.M. (Grant number 26070201), and grants of the Ministry Education, Culture, Sports, Science and Technology of Japan to E.M. (Grant number 15K08643), A.S. (Grant number 25462818) and H.A. (Grant number 15K19176).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eriko Morishita.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamijima, S., Sekiya, A., Takata, M. et al. Gene analysis of inherited antithrombin deficiency and functional analysis of abnormal antithrombin protein (N87D). Int J Hematol 107, 490–494 (2018). https://doi.org/10.1007/s12185-017-2352-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-017-2352-8

Keywords

Navigation